These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 7513398)
21. Systemic coagulation and fibrinolysis in patients with or at risk for the adult respiratory distress syndrome. Groeneveld AB; Kindt I; Raijmakers PG; Hack CE; Thijs LG Thromb Haemost; 1997 Dec; 78(6):1444-9. PubMed ID: 9423792 [TBL] [Abstract][Full Text] [Related]
22. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction. Saigo M; Abe S; Ogawa M; Yamashita T; Biro S; Minagoe S; Maruyama I; Tei C Thromb Haemost; 2001 Nov; 86(5):1197-203. PubMed ID: 11816707 [TBL] [Abstract][Full Text] [Related]
23. WAY-140312 reduces plasma PAI-1 while maintaining normal platelet aggregation. Crandall DL; Hennan JK; Elokdah H; Krishnamurthy G; Antrilli TM; Bauer JS; Morgan GA; Swillo RE Biochem Biophys Res Commun; 2003 Nov; 311(4):904-8. PubMed ID: 14623266 [TBL] [Abstract][Full Text] [Related]
24. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations. Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154 [TBL] [Abstract][Full Text] [Related]
25. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy]. Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582 [TBL] [Abstract][Full Text] [Related]
26. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults. Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281 [TBL] [Abstract][Full Text] [Related]
27. Effect of low-dose aspirin during pregnancy on fibrinolytic variables before and after parturition. Bremer HA; Rotmans N; Brommer EJ; Wallenburg HC Am J Obstet Gynecol; 1995 Mar; 172(3):986-91. PubMed ID: 7892894 [TBL] [Abstract][Full Text] [Related]
28. Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas. Hoshino M; Haraguchi Y; Hirasawa H; Sakai M; Saegusa H; Hayashi K; Horita N; Ohsawa H Crit Care; 2001; 5(2):88-99. PubMed ID: 11299067 [TBL] [Abstract][Full Text] [Related]
29. [Indirect comparison of changes of parameters of hemostasis during short-term use of ticlopidine and clopidogrel in patients with non-ST elevation acute coronary syndrome]. Slavina NN; Averkov OV; Gratsianskiĭ NA Kardiologiia; 2005; 45(12):11-6. PubMed ID: 16353041 [TBL] [Abstract][Full Text] [Related]
30. Administration of testosterone improves the prothrombotic and antifibrinolytic parameters associated with its deficiency in an orchidectiomized rat model. Alqahtani SA; Alhawiti NM Platelets; 2019; 30(5):624-630. PubMed ID: 30102104 [TBL] [Abstract][Full Text] [Related]
31. Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus. Bronisz A; Rosc D; Bronisz M; Szymanski W; Junik R Med Sci Monit; 2008 Nov; 14(11):CR574-9. PubMed ID: 18971874 [TBL] [Abstract][Full Text] [Related]
32. Hemostatic Adaptations to High Intensity Interval Training in Healthy Adult Men. Sackett JR; Farrell DP; Nagelkirk PR Int J Sports Med; 2020 Oct; 41(12):867-872. PubMed ID: 32634847 [TBL] [Abstract][Full Text] [Related]
33. Influence of aspirin or heparin on platelet function and postoperative blood loss after coronary artery bypass surgery. Sirvinskas E; Veikutiene A; Grybauskas P; Cimbolaityte J; Mongirdiene A; Veikutis V; Raliene L Perfusion; 2006 Jan; 21(1):61-6. PubMed ID: 16485701 [TBL] [Abstract][Full Text] [Related]
34. Effect of pulsed estrogen therapy on hemostatic markers in comparison with oral estrogen regimen in postmenopausal women. Basurto L; Saucedo R; Zárate A; Martínez C; Gaminio E; Reyes E; Hernandez M Gynecol Obstet Invest; 2006; 61(2):61-4. PubMed ID: 16192735 [TBL] [Abstract][Full Text] [Related]
35. The in vitro effects of Xancor, a synthetic astaxanthine derivative, on hemostatic biomarkers in aspirin-naïve and aspirin-treated subjects with multiple risk factors for vascular disease. Serebruany V; Malinin A; Goodin T; Pashkow F Am J Ther; 2010; 17(2):125-32. PubMed ID: 20305399 [TBL] [Abstract][Full Text] [Related]
36. Fibrinolytic imbalance in essential thrombocythemia: role of platelets. Bazzan M; Tamponi G; Gallo E; Stella S; Schinco PC; Pannocchia A; Pileri A Haemostasis; 1993; 23(1):38-44. PubMed ID: 8477907 [TBL] [Abstract][Full Text] [Related]
37. Activation of the coagulation system during coronary artery bypass grafting: comparison between on-pump and off-pump techniques. Paparella D; Galeone A; Venneri MT; Coviello M; Scrascia G; Marraudino N; Quaranta M; de Luca Tupputi Schinosa L; Brister SJ J Thorac Cardiovasc Surg; 2006 Feb; 131(2):290-7. PubMed ID: 16434256 [TBL] [Abstract][Full Text] [Related]
38. Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels. Bjornsson TD; Schneider DE; Berger H J Pharmacol Exp Ther; 1989 Jul; 250(1):154-61. PubMed ID: 2746495 [TBL] [Abstract][Full Text] [Related]
39. Modulation of fibrinolytic response to venous occlusion in humans by a combination of low-dose aspirin and n-3 polyunsaturated fatty acids. Iacoviello L; Amore C; De Curtis A; Tacconi MT; de Gaetano G; Cerletti C; Donati MB Arterioscler Thromb; 1992 Oct; 12(10):1191-7. PubMed ID: 1390591 [TBL] [Abstract][Full Text] [Related]
40. Effects of a protease inhibitor, ulinastatin, on coagulation and fibrinolysis in abdominal surgery. Nishiyama T; Yokoyama T; Yamashita K J Anesth; 2006; 20(3):179-82. PubMed ID: 16897236 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]